274 related articles for article (PubMed ID: 14709623)
1. Characterization of N-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human liver: importance of UDP-glucuronosyltransferase 1A4.
Wiener D; Doerge DR; Fang JL; Upadhyaya P; Lazarus P
Drug Metab Dispos; 2004 Jan; 32(1):72-9. PubMed ID: 14709623
[TBL] [Abstract][Full Text] [Related]
2. Correlation between UDP-glucuronosyltransferase genotypes and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone glucuronidation phenotype in human liver microsomes.
Wiener D; Fang JL; Dossett N; Lazarus P
Cancer Res; 2004 Feb; 64(3):1190-6. PubMed ID: 14871856
[TBL] [Abstract][Full Text] [Related]
3. Role of l- and d-Menthol in the Glucuronidation and Detoxification of the Major Lung Carcinogen, NNAL.
Kozlovich S; Chen G; Watson CJW; Blot WJ; Lazarus P
Drug Metab Dispos; 2019 Dec; 47(12):1388-1396. PubMed ID: 31578206
[TBL] [Abstract][Full Text] [Related]
4. Genotype-phenotype correlation between the polymorphic UGT2B17 gene deletion and NNAL glucuronidation activities in human liver microsomes.
Lazarus P; Zheng Y; Runkle EA; Muscat JE; Wiener D
Pharmacogenet Genomics; 2005 Nov; 15(11):769-78. PubMed ID: 16220109
[TBL] [Abstract][Full Text] [Related]
5. Association between Glucuronidation Genotypes and Urinary NNAL Metabolic Phenotypes in Smokers.
Chen G; Luo S; Kozlovich S; Lazarus P
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1175-1184. PubMed ID: 27197298
[TBL] [Abstract][Full Text] [Related]
6. O-Glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanol (NNAL) by human UDP-glucuronosyltransferases 2B7 and 1A9.
Ren Q; Murphy SE; Zheng Z; Lazarus P
Drug Metab Dispos; 2000 Nov; 28(11):1352-60. PubMed ID: 11038164
[TBL] [Abstract][Full Text] [Related]
7. Glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by rat UDP-glucuronosyltransferase 2B1.
Ren Q; Murphy SE; Dannenberg AJ; Park JY; Tephly TR; Lazarus P
Drug Metab Dispos; 1999 Sep; 27(9):1010-6. PubMed ID: 10460800
[TBL] [Abstract][Full Text] [Related]
8. Stereospecific Metabolism of the Tobacco-Specific Nitrosamine, NNAL.
Kozlovich S; Chen G; Lazarus P
Chem Res Toxicol; 2015 Nov; 28(11):2112-9. PubMed ID: 26452127
[TBL] [Abstract][Full Text] [Related]
9. Prominent Stereoselectivity of NNAL Glucuronidation in Upper Aerodigestive Tract Tissues.
Kozlovich S; Chen G; Watson CJW; Lazarus P
Chem Res Toxicol; 2019 Aug; 32(8):1689-1698. PubMed ID: 31307193
[TBL] [Abstract][Full Text] [Related]
10. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
Carmella SG; Borukhova A; Akerkar SA; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
[TBL] [Abstract][Full Text] [Related]
11. Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers and metabolites in the A/J mouse.
Upadhyaya P; Kenney PM; Hochalter JB; Wang M; Hecht SS
Carcinogenesis; 1999 Aug; 20(8):1577-82. PubMed ID: 10426810
[TBL] [Abstract][Full Text] [Related]
12. Analysis of N- and O-glucuronides of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine.
Carmella SG; Le Ka KA; Upadhyaya P; Hecht SS
Chem Res Toxicol; 2002 Apr; 15(4):545-50. PubMed ID: 11952341
[TBL] [Abstract][Full Text] [Related]
13. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine.
Carmella SG; Akerkar SA; Richie JP; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):635-42. PubMed ID: 8547830
[TBL] [Abstract][Full Text] [Related]
14. Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine.
Carmella SG; Han S; Fristad A; Yang Y; Hecht SS
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1257-61. PubMed ID: 14652291
[TBL] [Abstract][Full Text] [Related]
15. Characterization of benzo(a)pyrene-trans-7,8-dihydrodiol glucuronidation by human tissue microsomes and overexpressed UDP-glucuronosyltransferase enzymes.
Fang JL; Beland FA; Doerge DR; Wiener D; Guillemette C; Marques MM; Lazarus P
Cancer Res; 2002 Apr; 62(7):1978-86. PubMed ID: 11929814
[TBL] [Abstract][Full Text] [Related]
16. Identification of a prevalent functional missense polymorphism in the UGT2B10 gene and its association with UGT2B10 inactivation against tobacco-specific nitrosamines.
Chen G; Dellinger RW; Gallagher CJ; Sun D; Lazarus P
Pharmacogenet Genomics; 2008 Mar; 18(3):181-91. PubMed ID: 18300939
[TBL] [Abstract][Full Text] [Related]
17. Influence of UGT2B10 Genotype on Urinary Excretion of 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol- N-glucuronide by African American Smokers.
Murphy SE; von Weymarn LB; Parenteau M; Stepanov I; Tiirikainen M; LeMarchand L; Park SL
Chem Res Toxicol; 2018 Mar; 31(3):168-175. PubMed ID: 29460622
[TBL] [Abstract][Full Text] [Related]
18. Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers.
Richie JP; Carmella SG; Muscat JE; Scott DG; Akerkar SA; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):783-90. PubMed ID: 9332760
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of pyridylhydroxybutyl-DNA adducts in liver and lung of F-344 rats treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.
Upadhyaya P; Kalscheuer S; Hochalter JB; Villalta PW; Hecht SS
Chem Res Toxicol; 2008 Jul; 21(7):1468-76. PubMed ID: 18570389
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation.
Hecht SS; Carmella SG; Chen M; Dor Koch JF; Miller AT; Murphy SE; Jensen JA; Zimmerman CL; Hatsukami DK
Cancer Res; 1999 Feb; 59(3):590-6. PubMed ID: 9973205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
